| Metabolic-dysfunction-associated fatty liver disease and gut microbiota: From fatty liver to dysmetabolic syndrome L Abenavoli, GGM Scarlata, E Scarpellini, L Boccuto, R Spagnuolo, ... Medicina 59 (3), 594, 2023 | 28 | 2023 |
| Is the pendulum of antimicrobial drug resistance swinging back after COVID-19? F Serapide, A Quirino, V Scaglione, HL Morrone, F Longhini, A Bruni, ... Microorganisms 10 (5), 957, 2022 | 27 | 2022 |
| Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions D Bongiorno, DA Bivona, C Cicino, EM Trecarichi, A Russo, N Marascio, ... Frontiers in cellular and infection microbiology 12, 1010979, 2023 | 15 | 2023 |
| Ultrasound prevalence and clinical features of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A real-life cross-sectional study L Abenavoli, R Spagnuolo, GGM Scarlata, E Scarpellini, L Boccuto, ... Medicina 59 (11), 1935, 2023 | 12 | 2023 |
| Gut microbiota and liver transplantation: immune mechanisms behind the rejection L Abenavoli, GGM Scarlata, MR Paravati, L Boccuto, F Luzza, ... Biomedicines 11 (7), 1792, 2023 | 12 | 2023 |
| Perspective on the role of gut microbiome in the treatment of hepatocellular carcinoma with immune checkpoint inhibitors L Abenavoli, M Montori, G Svegliati Baroni, ME Argenziano, F Giorgi, ... Medicina 59 (8), 1427, 2023 | 9 | 2023 |
| Post-Coronavirus disease 2019 pandemic antimicrobial resistance L Boccabella, EG Palma, L Abenavoli, GGM Scarlata, M Boni, G Ianiro, ... Antibiotics 13 (3), 233, 2024 | 7 | 2024 |
| Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease C Colaci, ML Gambardella, GGM Scarlata, L Boccuto, C Colica, F Luzza, ... | 7 | 2024 |
| Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition L Abenavoli, E Scarpellini, MR Paravati, GGM Scarlata, L Boccuto, ... Nutrients 15 (16), 3569, 2023 | 6 | 2023 |
| The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation L Abenavoli, ML Gambardella, GGM Scarlata, I Lenci, L Baiocchi, F Luzza Medicina 60 (4), 563, 2024 | 5 | 2024 |
| The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives N Marascio, GGM Scarlata, F Romeo, C Cicino, EM Trecarichi, A Quirino, ... International Journal of Molecular Sciences 24 (11), 9307, 2023 | 5 | 2023 |
| Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital A Quirino, C Cicino, GGM Scarlata, N Marascio, G Di Gennaro, G Matera, ... Antibiotics 12 (10), 1525, 2023 | 4 | 2023 |
| Orthopedic device-related infections due to emerging pathogens diagnosed by a combination of microbiological approaches: case series and literature review A Quirino, N Marascio, GGM Scarlata, C Cicino, G Pavia, M Pantanella, ... Diagnostics 12 (12), 3224, 2022 | 4 | 2022 |
| HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) N Marascio, M Mazzitelli, GGM Scarlata, A Giancotti, GS Barreca, ... The Open Microbiology Journal 14 (1), 2020 | 4 | 2020 |
| Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series L Abenavoli, I Aquila, MA Sacco, GGM Scarlata, AC Procopio, L Boccuto, ... Diseases 11 (4), 141, 2023 | 3 | 2023 |
| Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study MR Paravati, AC Procopio, M Milanović, GGM Scarlata, N Milošević, ... Nutrients 16 (8), 1226, 2024 | 2 | 2024 |
| Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era R Spagnuolo, GGM Scarlata, MR Paravati, L Abenavoli, F Luzza Antibiotics 13 (4), 357, 2024 | 2 | 2024 |
| Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway? L Abenavoli, GG Scarlata, E Scarpellini, AC Procopio, FR Ponziani, ... Minerva Gastroenterology, 2024 | 2 | 2024 |
| Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma GGM Scarlata, C Cicino, R Spagnuolo, N Marascio, A Quirino, G Matera, ... | 2 | 2024 |
| Changing epidemiology of hepatitis C in Italy: a population-based survey in a historically high endemic area E Spada, C Marcantonio, MF Vescio, N Marascio, U Villano, G Pisani, ... Minerva medica 114 (2), 191-202, 2023 | 2 | 2023 |
Ludovico AbenavoliMagna Graecia University of Catanzaro, ItalyVerified email at unicz.it
